Company record
Atlas Bio
Updated October 30, 2026 · Presspool
Uses a foundation AI model of human biology to run in silico clinical trials. atlas.bio
Funding
Latest announced financing: $10 million, seed, led by Creandum, announced October 27, 2026.
- $10 million seed, announced October 27, 2026. Led by Creandum. Listed in the AI startup funding roster for October 26–31, 2026. Sources: Tech.eu, European Biotechnology.
Of the 75 seed rounds announced in dollars on Presspool's weekly rosters since September 21, 2026, Atlas Bio's $10 million is the joint 21st largest; their median is $7 million.
Whether AI names Atlas Bio
- Machine Relations Index: Not cited in any Machine Relations Index answer, May 10, 2026 to October 29, 2026.
Related records
Closest rounds in the roster for October 26–31, 2026: ALLOX (US$10.5 million seed, October 29, 2026), Northstar Security ($7 million seed, October 28, 2026), Lette ($6.5 million seed, October 26, 2026), Ravical ($17 million seed, October 29, 2026), Nagare Labs ($5 million seed, October 26, 2026), Machenta ($40 million seed, October 27, 2026).
Creandum, which led this round, also led Machenta ($40 million seed, October 27, 2026), Turba Labs ($52 million Seed and Series A, October 6, 2026) and hosted·ai ($19M Seed, March 19, 2026). It is also named as an investor in Causa Prima ($20 million Seed, October 13, 2026), Scarlet ($50 million Series B, October 12, 2026) and Procuros (€20 million Series A, October 6, 2026).